The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of histological subtypes in patients receiving first-line treatment with enfortumab vedotin/pembrolizumab in advanced metastatic urothelial cancer.
 
Aya Abdelnaser
No Relationships to Disclose
 
Mitra Shavakhi
No Relationships to Disclose
 
Arvind Ravi
Stock and Other Ownership Interests - Halo Pharma
Consulting or Advisory Role - Halo Pharma; IBM (Inst); Tegus
 
Ilana Epstein
No Relationships to Disclose
 
Bicky Thapa
No Relationships to Disclose
 
Paloma Galera
No Relationships to Disclose
 
Mary-Ellen Taplin
Honoraria - Astellas Pharma; AstraZeneca; Blue Earth Diagnostics; Carden Jennings; Clovis Oncology; DAVA Pharmaceuticals; Flare Therapeutics; Interpublic GIS; Janssen-Ortho; MJH Healthcare Holdings, LLC; Novartis; Pfizer; Physicans' Education Resource; Propella Therapeutics; Research to Practice; UpToDate
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Blue Earth Diagnostics; Flare Therapeutics; Geode Therapeutics; Janssen-Ortho; Laekena; Novartis; Pfizer; Propella Therapeutics; UpToDate
Research Funding - Janssen-Ortho (Inst)
Travel, Accommodations, Expenses - Advanced Prostate Cancer Society; Prostate Cancer Foundation; South West Prostate Cancer Symposium
 
Joaquim Bellmunt
Stock and Other Ownership Interests - Rainier Therapeutics
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono/Merck; Merck; Novartis; Pfizer; Pierre Fabre
Research Funding - Pfizer/EMD Serono (Inst); Pfizer/Gilead
Patents, Royalties, Other Intellectual Property - UpToDate Bladder Cancer
Travel, Accommodations, Expenses - Genentech/Roche; Ipsen